A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma

Abstract 4898: Circulating tumor cell capture on a microfluidic chip incorporating both affinity and size

(2012) Keith Merdek et al.   CANCER RESEARCH

Abstract 4733: Function of cytoplasmic histone deacetylase 5 is required for HIF-1α stability

(2012) Shuyang Chen et al.   CANCER RESEARCH

Circulating Soluble CD30 and Future Risk of Lymphoma; Evidence from Two Prospective Studies in the General Population

(2011) R. Vermeulen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study

(2011) A. K. Chaturvedi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tumor Necrosis Factor (TNF) and Lymphotoxin-  (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium

(2010) C. F. Skibola et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study

(2010) Yian Gu et al.   CANCER CAUSES & CONTROL

Plasma Cytokines and Future Risk of Non-Hodgkin Lymphoma (NHL): A Case-Control Study Nested in the Italian European Prospective Investigation into Cancer and Nutrition

(2010) F. Saberi Hosnijeh et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

TNF receptor 2 pathway: drug target for autoimmune diseases

(2010) Denise Faustman et al.   NATURE REVIEWS DRUG DISCOVERY

Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance

(2009) Hiromichi Wada et al.   ATHEROSCLEROSIS

A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma

(2009) M. P. Purdue et al.   BLOOD

TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner

(2009) Wanhu Tang et al.   CELL RESEARCH

Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

(2008) C. Chao et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY